Treatment of cancer using Anti-CD19 chimeric antigen receptor
MYPI2025005468A0Undetermined Publication Date: 2015-10-07THE TRUSTEES OF THE UNIV OF PENNSYLVANIA +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025005468
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2015-04-07
- Filing Date
- 2015-04-07
- Publication Date
- 2015-10-07
Abstract
The invention provides compositions and methods for treating diseases associated with expression of CD19, e.g., by administering a recombinant T cell comprising the CD19 CAR as described herein, in combination with a kinase inhibitor, e.g., a kinase inhibitor described herein. The invention also provides kits and compositions described herein.
Need to check novelty before this filing date? Find Prior Art
